NanoSphere Health Sciences Inc.

NSHS

CA63010P2098

Pharmaceuticals

Delayed Canadian Securities Exchange Other stock markets 12:41:23 04/05/2024 am IST			5-day change	1st Jan Change
0.025 ^CAD	0.00%		0.00%	+150.00%

30/04	NanoSphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	NanoSphere Health Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

NanoSphere Health Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023

May 18, 2023 at 02:53 am IST

NanoSphere Health Sciences Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 0.053559 million compared to USD 0.06992 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.

Latest news about NanoSphere Health Sciences Inc.

NanoSphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30/04	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/11	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28/23/28	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	18/23/18	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	29/23/29	CI
NanoSphere Health Sciences Inc. Auditor Raises 'Going Concern' Doubt	28/23/28	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	25/22/25	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	03/22/03	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	25/22/25	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	26/22/26	CI
NanoSphere Health Sciences Inc. Auditor Raises 'Going Concern' Doubt	25/22/25	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	30/21/30	CI
NanoSphere Health Sciences Inc. announced that it expects to receive CAD 0.234 million in funding	17/21/17	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	31/21/31	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	01/21/01	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	30/21/30	CI
NanoSphere Health Sciences Inc. Auditor Raises 'Going Concern' Doubt	30/21/30	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	30/20/30	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	29/20/29	CI
Nanosphere Health Sciences Inc. Announces Earnings Results for the First Quarter Ended March 31, 2020	16/20/16	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	16/20/16	CI
NanoSphere Health Sciences Inc. Auditor Raises 'Going Concern' Doubt	15/20/15	CI
NanoSphere Health Sciences Inc. Announces Resignation of Mark Percival as CEO	21/20/21	CI
NanoSphere Health Sciences Inc. Provides Update on United States Operations	09/19/09	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	29/19/29	CI

Chart NanoSphere Health Sciences Inc.

Duration

Period

More charts

Company Profile

NanoSphere Health Sciences Inc. is a nano-biotechnology company. The Company is focused on providing delivery of biologically active compounds through licensing and joint venture arrangements. The Company has created a patented NanoSphere Deliver System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries. Its wholly owned subsidiary is NanoSphere Health Sciences, LLC (NanoSphere LLC). NanoSphere LLC is the Companyâs operating division in the United States.

Sector

Pharmaceuticals

Calendar

28/05/2024 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
NANOSPHERE HEALTH SCIENCES INC.	+150.00%	188K
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.28%	44.4B
OTSUKA HOLDINGS CO., LTD.	+24.60%	23.03B
SANDOZ GROUP AG	+19.22%	15.14B
CIPLA LIMITED	+12.87%	13.12B
ZYDUS LIFESCIENCES LIMITED	+44.67%	11.85B
ONO PHARMACEUTICAL CO., LTD.	-8.33%	6.99B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+12.22%	5.52B

Generic Pharmaceuticals